Literature DB >> 31411329

Zoledronic acid is effective and safe in migratory osteoporosis.

Gerasimos Evangelatos1, George E Fragoulis2,3, Evangelia Zampeli4, Maria Kechagia1, Alexios Iliopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31411329     DOI： 10.1093/rheumatology/kez345

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Zoledronic acid in nine patients with transient osteoporosis of the hip.

Authors:  Gerasimos Evangelatos; George E Fragoulis; Alexios Iliopoulos
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

2.  Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report.

Authors:  Gerasimos Evangelatos; George E Fragoulis; Athanasios D Anastasilakis; Alexios Iliopoulos
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

3.  Curative Effect of Prebiotics/Probiotics Preparations Combined with Zoledronic Acid + Calcitriol Regimen on Patients with Primary Osteoporosis and Their Influences on Bone Metabolism Markers.

Authors:  Ruipeng Jia; Ning Liu; Yanyan Zhu; Qiaoli Li
Journal:  Emerg Med Int       Date:  2022-07-21       Impact factor: 1.621
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.